Comments on COVID-19 and AL Amyloidosis, the Missing Links

Crees and Stockerl-Goldstein1 recently reviewed the management of light chain (AL) amyloidosis during the coronavirus disease 2019 (COVID-19) pandemic. While the literature discussed by authors is pertinent, certain lacunae in the diagnosis, prevention, and management need attention.
Source: The American Journal of Medicine - Category: General Medicine Authors: Tags: Letter Source Type: research